User:DannyARDD/sandbox

Aging Research for Drug Discovery Annual Conference - ARDD

Aging Research for Drug Discovery (ARDD) is the annual conference organized by the University of Copenhagen together with Columbia University. It covers a broad range of topics related to practical applications of aging research in research, drug discovery, drug development, and in the clinic. The conference transpires at the beginning of September in Basel, Switzerland. In 2020 the conference is in its 7th year and changed its format to all-digital.

History The conference series started as part of MipTec and Basel Life conference series in Basel, Switzerland in 2014 and was titled "The International Symposium on Geroprotectors" {REF1}. Since 2017 the conference is co-managed by the biology of aging laboratory at the University of Copenhagen. The attendance of the conference increased from 200 delegates in 2014 to over 500 in 2019.

Conference Proceedings Proceedings of the conference are commonly published in a peer-reviewed journal acting as a conference sponsor. In 2018, and 2019 the conference proceedings were published in Aging {Ref2, Ref3}

Notable facts In 2014, during its inaugural launch as part of the MipTec conference in Basel, Dr. Joerg Reinhardt, the chairman of Novartis, presented on the importance of aging research in drug discovery and development. Joan Mannick, of Novartis, presented her preliminary clinical trial results of RAD001 utilized for vaccine potentiation in the elderly.